U.S. Markets closed

I Like the Long Side of Bristol-Myers Squibb

Bruce Kamich

In his second "Executive Decision" segment during Wednesday night's Mad Money program, Jim Cramer sat down with Giovanni Caforio, chairman and CEO at Bristol-Myers Squibb Co. With the line close to its 2015 highs this speaks more of accumulation (buying) than distribution (selling).